Results 261 to 270 of about 386,755 (358)

Applications of Matrix Metalloproteinase-9-Related Nanomedicines in Tumors and Vascular Diseases. [PDF]

Pharmaceutics
Li X, Xu Z.
europepmc   +1 more source

Altered Bone Mechanics, Architecture and Composition in the Skeleton of TIMP-3-Deficient Mice [PDF]

, 2017
A Bruni-Cardoso, A Carriero, A Carriero, A Carriero, A Janssen, A Ural, Adele Boskey, AL Boskey, AL Boskey, Alessandra Carriero, Andrew A. Pitsillides, B Javaheri, Behzad Javaheri, BH Weber, Brendyn Miller, CH Turner, D Stickens, E Donnelly, E Ohuchi, EL Martin, EP Paschalis, FF Mohammed, George Bou-Gharios, H Isaksson, H Zhao, HH Malluche, J Verstappen, K Bell, K Brew, K Holmbeck, K Verdelis, KJ Leco, L Hammoud, L Spevak, Lyudmila Lukashova, Lyudmila Spevak, M Federici, M Inada, M Marzia, ME Marisa, ML Bouxsein, P Garnero, PW Fedak, R Ritchie, R Shigdel, S Sahebjam, S Verrier, SE Gill, SS Apte, T Maretzky, W Cruz-Munoz, Y Shen   +51 more
core   +3 more sources

Matrix metalloproteinase-9 deficiency attenuates diabetic nephropathy by modulation of podocyte functions and dedifferentiation.

Kidney International, 2014
Szu-yuan Li, Po‐Hsun Huang, A. Yang, D. Tarng, Wu-chang Yang, Chih-Ching Lin, Jaw-wen Chen, G. Schmid-Schönbein, Shing-Jong Lin   +8 more
semanticscholar   +1 more source

Modulation of Network Plasticity Opens Novel Therapeutic Possibilities in Cancer, Diabetes, and Neurodegeneration

Advanced Science, EarlyView.
Plasticity changes of molecular networks form a cellular learning process. Signaling network plasticity promotes cancer, metastasis, and drug resistance development. 55 plasticity‐related cancer drug targets are listed (20 having already approved drugs, 9 investigational drugs, and 26 being drug target candidates).
Márk Kerestély, István Narozsny, Levente Szarka, Daniel V. Veres, Peter Csermely, Dávid Keresztes   +5 more
wiley   +1 more source

Significant Association of Matrix Metalloproteinase-9 Polymorphisms With Triple Negative Breast Cancer Risk. [PDF]

Cancer Genomics Proteomics
Hung CC, Wang YC, Shih HY, Liu CH, He JL, Chen JC, Chang WS, Su CH, Bau DT, Tsai CW.   +9 more
europepmc   +1 more source

CXC Chemokine‐Driven Vascular Reprogramming: Modulating Tumor Vasculature to Boost Therapeutic Response

Advanced Science, EarlyView.
Tumor vascular remodeling is discussed from a chemokine‐centered perspective. This review summarizes the bidirectional, temporal, and tissue‐specific roles of CXC chemokines in regulating vascular function and immune accessibility. A functional vascular normalization score is introduced as a conceptual framework to integrate dynamic vascular and immune
Hongdan Chen, Yinde Huang, Juntong Wu, Ziying Yi, Yao Li, Zeyu Yang, Fan Zhang, Chong Li   +7 more
wiley   +1 more source

RETRACTION: Role of Matrix Metalloproteinase-9 Gene Polymorphisms in Glaucoma: A Hospital-Based Study in Chinese Patients. [PDF]

J Clin Lab Anal
europepmc   +1 more source

Serum matrix metalloproteinase-9 as a potential biomarker for obstructive sleep apnea severity. [PDF]

Sleep Breath
Kim SY, Yoon H, Choi SH, Cho J.
europepmc   +1 more source

Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction.

Journal of Clinical Investigation, 2000
A. Ducharme, S. Frantz, M. Aikawa, E. Rabkin, M. Lindsey, Luis E. Rohde, F. Schoen, R. Kelly, Z. Werb, P. Libby, R. Lee   +10 more
semanticscholar   +1 more source

Sound‐Based Assembly of Magnetically Actuated Soft Robots Toward Enhanced Release of Extracellular Vesicles

Advanced Intelligent Systems, Volume 7, Issue 3, March 2025.
Magnetic soft robots offer promise in biomedicine due to their wireless actuation and rapid response, but current fabrication methods are complex and have limited cellular compatibility. A new, contactless bioassembly strategy using hydrodynamic instabilities is introduced, enabling customizable, centimeter‐scale robots.
Wei Gao, Riccardo Tognato, Micaela Natta, Elena Della Bella, Alessandro Cianciosi, Tiziano Serra   +5 more
wiley   +1 more source